Rimbach, Germany

Lukas Schimunek

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of Pittsburgh. Active years: 2023.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Lukas Schimunek in Trauma Patient Stratification

Introduction

Lukas Schimunek is an innovative inventor based in Rimbach, Germany. He has made significant contributions to the field of trauma care through his research and inventions. His work focuses on improving the treatment and outcomes for blunt trauma patients.

Latest Patents

Lukas Schimunek holds a patent for a "Time window-based platform for the rapid stratification of blunt trauma patients into distinct outcome cohorts." This patent outlines methods for segregating trauma patients into different cohorts based on the risk of multiple organ dysfunction syndrome. The methods utilize patient data obtained within a short time window following injury, which is crucial for providing timely treatment to trauma patients.

Career Highlights

Lukas Schimunek is affiliated with the University of Pittsburgh, where he continues to advance his research in trauma care. His work has the potential to significantly impact how trauma patients are treated and categorized, ultimately improving patient outcomes.

Collaborations

Lukas has collaborated with notable colleagues, including Rami Namas and Timothy R. Billiar. Their combined expertise enhances the research and development of innovative solutions in the field of trauma medicine.

Conclusion

Lukas Schimunek's contributions to trauma patient stratification demonstrate his commitment to improving medical outcomes through innovation. His patent and ongoing research at the University of Pittsburgh highlight the importance of timely intervention in trauma care.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…